| source name | K562 |
|---|
| biomaterial provider | ATCC |
|---|
| treatment | None |
|---|
| datatype | ChipSeq |
|---|
| datatype description | Chromatin IP Sequencing |
|---|
| antibody antibodydescription | Rabbit polyclonal, EGR-1 (588). Antibody Target: EGR1 |
|---|
| antibody targetdescription | Egr-1, Egr-2, Egr-3 and Egr-4 are nuclear transcription factors belonging to the Egr C2H2-type zinc-finger protein family and containing three C2H2-type zinc fingers. As immediate early proteins, Egr transcription factors are rapidly induced by diverse extracellular stimuli. Egr proteins are subject to tight differential control through diverse mechanisms at several levels of regulation including transcriptional, translational and post-translational (including glyco- sylation, phosphorylation and redox) mechanisms and protein-protein inter- action. Egr-1 binds to the DNA sequence 5'-CGCCCCCGC-3' (EGR-site), there- by activating transcription of target genes whose products are required for mitogenisis and differentiation. Egr-2 binds specific DNA sites located in the promoter region of HoxA4. Egr-2 defects cause congenital hypomyelination neuropathy (also designated Charcot-Marie-tooth disease) and Dejerine- Sottas neuropathology (also designated hereditary motor and sensory neuro- pathy III. Egr-3 is involved in muscle spindle development and is expressed in T cells 20 minutes following activation. EGR-4 binds to the EGR consensus motif GCGTGGGCG, functions as a transcriptional repressor, and displays autoregulatory activities, downregulating its on gene promoter in a dose dependent manner. |
|---|
| antibody vendorname | Santa Cruz Biotechnology |
|---|
| antibody vendorid | sc-110 |
|---|
| controlid | SL2455 |
|---|
| labexpid | SL3164,SL3497 |
|---|
| replicate | 1,2 |
|---|
| softwareversion | MACS |
|---|
| antibody | Egr-1 |
|---|
| antibody antibodydescription | Rabbit polyclonal, EGR-1 (588). |
|---|
| antibody targetdescription | Egr-1, Egr-2, Egr-3 and Egr-4 are nuclear transcription factors belonging to the Egr C2H2-type zinc-finger protein family and containing three C2H2-type zinc fingers. As immediate early proteins, Egr transcription factors are rapidly induced by diverse extracellular stimuli. Egr proteins are subject to tight differential control through diverse mechanisms at several levels of regulation including transcriptional, translational and post-translational (including glyco- sylation, phosphorylation and redox) mechanisms and protein-protein inter- action. Egr-1 binds to the DNA sequence 5'-CGCCCCCGC-3' (EGR-site), there- by activating transcription of target genes whose products are required for mitogenisis and differentiation. Egr-2 binds specific DNA sites located in the promoter region of HoxA4. Egr-2 defects cause congenital hypomyelination neuropathy (also designated Charcot-Marie-tooth disease) and Dejerine- Sottas neuropathology (also designated hereditary motor and sensory neuro- pathy III. Egr-3 is involved in muscle spindle development and is expressed in T cells 20 minutes following activation. EGR-4 binds to the EGR consensus motif GCGTGGGCG, functions as a transcriptional repressor, and displays autoregulatory activities, downregulating its on gene promoter in a dose dependent manner. |
|---|
| antibody vendorname | Santa Cruz Biotech |
|---|
| antibody vendorid | sc-110 |
|---|
| treatment description | No special treatment or protocol applies |
|---|
| protocol | v041610.1 |
|---|
| protocol description | 2x10^7 cells, fragmentation by bioruptor, one 15-cycle round of PCR (Myers) |
|---|
| controlid | SL2455 |
|---|
| labexpid | SL3164 |
|---|
| replicate | 1 |
|---|
| replicate description | tier 1 |
|---|